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For people with type 2 diabetes mellitus (T2DM) the daily maintenance of physical and
psychological health is challenging. However, the interrelatedness of these two health
domains, and of diabetes-related distress (DRD) and depressive symptoms, in the Asian
population is still poorly understood. DRD and depressive symptoms have important but
distinct influences on diabetes self-care and disease control. Furthermore, the question
of whether changes in DRD or depressive symptoms follow a more or less natural course
or depend on disease and therapy-related factors is yet to be answered. The aim of this
study was to identify the factors influencing changes in DRD or depressive symptoms, at
a 3-year follow-up point, in Malaysian adults with T2DM who received regular primary
diabetes care. Baseline data included age, sex, ethnicity, marital status, educational
level, employment status, health-related quality of life (WHOQOL-BREF), insulin use,
diabetes-related complications and HbA1c. DRD was assessed both at baseline and
after 3 years using a 17-item Diabetes Distress Scale (DDS-17), while depressive
symptoms were assessed using the Patient Health Questionnaire (PHQ-9). Linear mixed
models were used to examine the relationship between baseline variables and change
scores in DDS-17 and PHQ-9. Almost half (336) of 700 participants completed both
measurements. At follow-up, their mean (SD) age and diabetes duration were 60.6 (10.1)
years and 9.8 (5.9) years, respectively, and 54.8% were women. More symptoms of
depression at baseline was the only significant and independent predictor of improved
DRD at 3 years (adjusted β = −0.06, p = 0.002). Similarly, worse DRD at baseline was
the only significant and independent predictor of fewer depressive symptoms 3 years
later (adjusted β = −0.98, p = 0.005). Thus, more “negative feelings” at baseline could
be a manifestation of initial coping behaviors or a facilitator of a better psychological
coaching by physicians or nurses that might be beneficial in the long term. We therefore
conclude that initial negative feelings should not be seen as a necessarily adverse factor
in diabetes care.
Keywords: diabetes distress, depression, type 2 diabetes mellitus, quality of life, complications, HbA1c, primary
care
Trial registration: NCT02730754 https://clinicaltrials.gov/ct2/show/NCT02730754.
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INTRODUCTION
It is acknowledged that type 2 diabetes mellitus (T2DM)
related psychological health deserves more attention (Scottish
Intercollegiate Guidelines Network, 2010; Chan and Luk, 2016;
Young-Hyman et al., 2016). Sources of psychological problems
could arise from complex medical therapeutic regimens, worries
about hypoglycemia and the complications of diabetes (Stuckey
et al., 2014), unfavorable living environments and a lack of social
support to adhere to medical advice (Hinder and Greenhalgh,
2012).
Consequently, a person’s self-management behavior is pivotal
to achieving good cardiometabolic control in adults with T2DM
(Powers et al., 2015), and might also influence clinical outcomes
(Dailey, 2011). As well as diabetes-specific knowledge, issues
such as diabetes-related distress (DRD) and depressive symptoms
(Ciechanowski et al., 2000) and their effective management
(Schulman-Green et al., 2012) have been shown to affect self-
management and quality of life in adults with T2DM (Thorpe
et al., 2013; Fisher et al., 2014). DRD is defined as a patient’s
concern about disease management, support, emotional burden
and access to care (Polonsky et al., 2005); it is an important
condition and is distinct from depression (Fisher et al., 2014). The
concept of DRD attempts to capture the emotional experiences of
people with diabetes mellitus, and is content and context-specific
to living with diabetes mellitus. Previous trials showed that DRD
has a higher prevalence and incidence than major depressive
disorders (Fisher et al., 2007, 2008). Earlier confusion of DRD
and depression has now been addressed and it was proposed that
“emotional distress” as a term that could cover both depression
and DRD (Fisher et al., 2014). It is likely that DRD is at the
milder end (but specific to diabetes) and depression is at the more
severe but general end of the spectrum of mental health problems
(Das-Munshi et al., 2007; Fisher et al., 2007). Additionally, both
DRD and depressive symptoms are not static concepts and are
likely to change over time. In Europeans with T2DM, DRD was
associated with the duration of diabetes and this association
could be largely explained by the presence of diabetes-related
microvascular complications and insulin treatment (Kasteleyn
et al., 2015).
Major depressive disorder was a significant and independent
predictor of severe DRD (mean DDS-17 ≥ 3) at 18 months
follow-up in people with T2DM in a study from theUnited States.
Other predictors included female gender, experiencing more
life or chronic stress, a high number of diabetes-related
complications, as well as poor diet or a low exercise level (Fisher
et al., 2009). In another study, depressive symptoms in people
with T2DM were not significantly associated with DRD at 6
months (Ehrmann et al., 2015). However, if depressive symptoms
were present at baseline, the risk of persistent DRD was almost
6-fold higher. Conversely, elevated DRD at baseline led to a 2.6-
fold increase in the incidence of depressive symptoms 6 months
later. In addition, female gender was a significant risk factor for
persistent DRD. Younger age, a higher BMI, a higher number
of physical comorbidities, female gender and not being married
were significantly related to higher levels of DRD and depressive
symptoms after 1 year. The same factors, with the exception of
female gender, were also significantly associated with DRD at
2-years follow-up (Burns et al., 2015).
The above-mentioned studies generally showed the expected
positive associations between DRD and depressive symptoms
longitudinally. However, whether a change in distress or
depressive symptoms is a more or less natural process or depends
on disease and therapy-related factors is not well understood.
A better understanding of which baseline factors are related
to changes in DRD and depressive symptoms over time could
facilitate effective psychological interventions (Gallo et al., 2005;
Fisher et al., 2009, 2014; Thorpe et al., 2013; Ducat et al., 2014).
This study aimed to identify factors, in Malaysian adults with
T2DM in primary care, that relate to changes in DRD and
depressive symptoms after 3 years of follow-up. The impact of
baseline demographics, health-related quality of life, and medical
characteristics (insulin therapy, diabetes-related complications
and HbA1c) on DRD and depressive symptoms were explored.
MATERIALS AND METHODS
This is a cohort study that included baseline and follow-up
data from a previous study, together with recent 3-year follow-
up data (Chew et al., 2016b). During this period of follow-up,
patients received standard diabetes care and clinical services at
the respective health clinics. The study was approved by the
Medical Research Ethics Committee (MREC), Ministry of Health
Malaysia.
Setting and Participants
All people who participated in the earlier study (Chew et al.,
2016b) and who returned for a follow-up visit to one of three
public health clinics in Malaysia were re-invited. Patients who
expressed suicidal thoughts or showed disturbed emotions at
baseline or during the follow-up period were referred to the
clinic’s doctor for immediate assessment. Some were included
in the follow-up cohort, whereas others were not, depending
on whether they returned for the diabetes follow-up visit.
Participants belonging to the cohorts were identified by an orange
label on their follow-up cards and on their medical records.
These health clinics were chosen because they serve different
sections of the local population. One health clinic is urban and
is visited mainly by patients of Chinese descent, the second is
a rural clinic visited by proportionally more patients of Indian
descent than found in a usual public health clinic, and the third
clinic is in a rural and predominantly ethnic Malay residential
area.
Participants were sampled consecutively as they came to the
clinics over a period of 6 months in 2016. Inclusion criteria
at baseline: age 30 years or older, a diagnosis of T2DM more
than 1 year ago, and with at least three clinic visits in the
previous year. The baseline exclusion criteria were pregnancy or
lactating, psychiatric/psychological disorders that could impair
judgment and memory, and participants who could not read or
understand English, Malay or Mandarin (Chew et al., 2016b).
Before the questionnaires were filled in, all participants gave
written consent in their preferred language while waiting for a
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medical consultation with the clinic’s doctor. Trained research
assistants interviewed participants who were not able to self-
administer the questionnaires.
Data Collection
Baseline demographic data including age, gender, ethnicity,
religion, educational level, employment status and monthly
income were included in the questionnaires. Structured case
record forms were used for data collection from the medical
records and included the duration of diabetes, HbA1c, diabetes-
related complications, blood pressure, lipids, number and type of
medication use (Chew et al., 2016b).
Data on hypertension (systolic blood pressure ≥ 130mm
Hg or diastolic blood pressure ≥ 80mm Hg), dyslipidemia
(LDL-cholesterol > 2.6 mmol/L or triglyceride > 1.7 mmol/L
or HDL-cholesterol < 1.1 mmol/L, as well as diabetes-related
complications (retinopathy, nephropathy and diabetic foot
problems; or ischemic heart disease and cerebrovascular disease
or stroke) were retrieved from the medical records (Chew et al.,
2016b).
DRD and depressive symptoms were measured using the 17-
item Diabetes Distress Scale (DDS-17) (Polonsky et al., 2005;
Ting et al., 2011; Chew et al., 2015c) and the Patient Health
Questionnaire (PHQ-9) (Kroenke et al., 2001; Sherina et al.,
2012; Yu et al., 2012), respectively. Former studies in Malaysia
supported the use of these questionnaires in Malay, English
and Chinese (Chew et al., 2015a,b,c, 2016b). DDS-17 yields a
total scale score plus four sub-scale scores: emotional burden,
physician distress, regimen distress and interpersonal distress,
with mean scores ranging between 1 and 6, with higher scores
representing more DRD (Polonsky et al., 2005). PHQ-9 has a
score range of 0–27, with higher scores denoting worse depressive
symptoms (Kroenke et al., 2001; Sherina et al., 2012; Yu et al.,
2012). The quality of life at baseline wasmeasured with theWorld
Health Organization Quality of Life- Brief (WHOQOL-BREF)
(Yao et al., 2002; Hasanah et al., 2003; Skevington et al., 2004).
DRD and depressive symptoms were measured again at follow-
up but without use of the WHOQOL-BREF. All questionnaires
used were locally validated and were prepared in three languages:
English, Malay and Mandarin.
Data Analysis
Data analyses were carried out using PASW 21.0 (SPSS, Chicago,
IL). Patient characteristics are presented as mean (SD) or median
(IQR) for continuous variables, and counts and percentages
for nominal variables using descriptive statistics. Comparisons
of mean levels were performed using the Student’s t-test or
Mann-Whitney U test for unpaired samples, and the Chi-
square test was used for proportionate samples between the
participants and non-participants. The determinant-outcome
relations for each factor were analyzed with linear mixed
models, with a change in DRD and a change in depressive
symptoms after 3 years follow-up as the dependent variables.
The change scores were calculated by subtracting the scores
in 2016 from the scores in 2013. A positive change score
indicates an increase in DRD or depressive symptoms, while
a negative change score denotes a reduction in emotional
distress. These change scores capture changes at a personal level.
Obviously, higher distress at baseline makes it more likely that
this distress decreases over time (via regression to the mean,
or via intervention). This decrease could then be accompanied
by a decrease in depressive symptoms. Nevertheless, in using
change scores we did not adjust for baseline scores since this
might have caused biased parameter estimates (Glymour et al.,
2005).
The linear mixed effect modeling incorporated the effect
of time expressed as the intercept. We chose to analyze
change scores because there were only two-time points in this
study and the follow-up time was nearly identical for each
subject. A random intercept per healthcare center was used to
account for clustering. Fixed effects were used for the above-
mentioned baseline patient and disease-related characteristics.
These covariates were chosen based on past studies (age, gender,
ethnicity, quality of life and insulin therapy) (Chew et al., 2015b,
2016a) and the baseline cross-sectional study in 2013 (marital
status, educational levels, employment status, diabetes-related
complications) (Chew et al., 2016b). Statistical significance was
set at p < 0.05.
RESULTS
Cohort Characteristics
In total, 336 participants completed the follow-upmeasurements,
representing nearly half of the baseline sample (n = 700)
(Table 1). Their mean (SD) age and diabetes duration were 60.6
(10.1) and 6.8 (5.8) years, respectively. Men and women were
nearly equally represented (54.8% women). The majority of the
participants were Malay, were married, and educated at least up
to secondary school level (Table 1).
Most participants lost to follow-up “could not be reached or
located” (n= 301), some switched to care elsewhere (n= 37), one
was confirmed deceased and 25 declined further participation.
Compared to the participants, the non-participants differed
significantly in several aspects with regard to their baseline
measures: they were more often treated at the rural Salak
Health Clinic (70.1, 20.1% at Seri Kembangan and 9.9% at
Dengkil, p < 0.001), a lower proportion achieved blood pressure
< 130/80 mmHg (21.7% vs. 33.0%, p = 0.001), and had
dyslipidemia (23.0% vs. 57.3%, p < 0.001). Insulin therapy was
also more often prescribed for non-participants (40.4 vs. 37.5%,
p < 0.001) (Table 1). At baseline, participants had a higher
overall DDS-17 score compared to non-participants. Participants
had higher mean scores on physician distress, regimen distress
and interpersonal distress compared to the non-participants, but
did not differ on emotional burden (Table 1). Participants and
non-participants did not differ in total PHQ-9 scores (Table 1).
Out of the six patients who had severe depressive symptoms
(total PHQ-9 score ≥ 20) at baseline, five participated and one
was lost to follow-up. Non-participants had a significantly lower
total number of clinic visits (mean 12.6 vs. 13.9, p = 0.004) but a
higher number of hospital referrals (mean 1.7 vs. 1.2, p < 0.001)
and visits to other healthcare professionals (mean 1.0 vs. 0.6,
p= 0.048).
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TABLE 1 | Baseline characteristics of the participants and non-participants in percentages, unless otherwise stated.
Baseline characteristics Participants n= 336 Non-participants n = 364 p-value
Seri Kembangan/Dengkil/Salak (% of cohort) 44.9/25.9/29.2 20.1/9.9/70.1 <0.001
Age in year, mean (SD) 60.6 (10.14) 59.3 (10.20) 0.106
Diabetes duration in year, mean (SD) 6.8 (5.78) 6.2 (5.59) 0.160
Gender Female 184 (54.8) 184 (50.5) 0.265
Ethnicity* Malay 147 (43.8) 220 (60.4) <0.001
Chinese 110 (32.7) 52 (14.3)
Indian 75 (22.3) 90 (24.7)
Others 4 (1.2) 2 (0.5)
Marital status Married/living with partner 268 (80.2) 283 (78.2) 0.642
Education level No and Primary education 155 (46.7) 149 (41.8) 0.051
Secondary 152 (45.8) 158 (44.3)
Tertiary 25 (7.5) 50 (14.0)
Employment Employed 148 (44.2) 167 (46.1) 0.931
Retired 83 (24.8) 89 (24.6)
Unemployed/ homemaker 104 (31.2) 106 (29.3)
HbA1c in mmol/mol and %, mean (SD) 68 (22.2) 8.4 (2.03) 68 (24.4) 8.4 (2.23) 0.160
Hypertension (n = 688) 264 (80.2) 275 (76.6) 0.267
BP < 130/80 mmHg 111 (33.0) 79 (21.7) 0.001
Dyslipidemia (n = 673) 184 (57.3) 81 (23.0) <0.001
LDL-C ≤ 2.6 mmol/L (n = 566) 121 (41.2) 108 (39.7) 0.733
Oral anti-diabetic agents (n = 695) 310 (92.8) 324 (89.8) 0.180
Insulin therapy (n = 694) 125 (37.5) 146 (40.4) <0.001
Microvascular complications 28 (8.3) 25 (6.9) 0.479
Macrovascular complications 18 (5.4) 24 (6.6) 0.527
Total WHOQOL-BREF, mean (SD) 61.1 (10.14) 62.2 (9.57) 0.144
Overall DDS-17, mean (SD) 2.3 (1.02) 2.1 (0.84) 0.023
Emotional burden, mean (SD) 2.4 (1.13) 2.4 (1.01) 0.784
Physician distress, mean (SD) 2.1 (1.21) 1.8 (1.11) 0.005
Regimen distress, mean (SD) 2.4 (1.10) 2.2 (0.98) 0.031
Interpersonal distress, mean (SD) 2.3 (1.33) 2.0 (1.08) 0.007
Total PHQ-9 score, mean (SD) 4.8 (4.47) 4.5 (4.15) 0.338
*Others included aborigines and other ethnicities. DDS-17, the 17-item diabetes distress scale, with mean scores ranging from 1 to 6; PHQ-9, the 9-item patient health questionnaire,
with total scores ranging from 0 to 27; SD, standard deviation; WHOQOL-BREF, World Health Organization Quality of Life-Brief.
Follow-Up Results
Correlations between overall baseline DDS-17 scores and PHQ-
9 change scores were negative, as were correlations between
baseline PHQ-9 scores and DDS-17 overall change scores
(Figure 1). Table 2 shows the baseline, follow-up and change
scores for the mean DDS-17 and total PHQ-9 scores of the
participants. The overall DDS-17 and emotional burden subscale
scores and the PHQ-9 scores increased slightly but the other
scores remained the same or decreased slightly, suggesting that
DRD and depressive symptoms did not change significantly over
3 years in the participating cohorts as a whole. Though the mean
DDS-17 and PHQ-9 change scores were close to 0 (Table 2),
there was considerable variation among participants: change
scores varied from –4.53 to +4.24 and from −23.00 to +24.00,
respectively.
Predictive Factors for DDS-17 and PHQ-9
After adjustment for demographic and clinical covariates in the
DDS-17 change model, only PHQ-9 at baseline explained the
change in DDS-17, with the higher PHQ-9 score at baseline
associated with lower DDS-17 scores at follow-up. An increase
of 10 points on baseline PHQ-9 was associated, on average, with
a 0.6 mean score decrease in DDS-17 (Table 3). For the PHQ-
9 change models, the baseline overall DDS-17 and interpersonal
distress subscale scores (in two separate models) showed negative
relations with PHQ-9 change scores; an increase of 1 in the
mean score on the DDS-17 and the interpersonal distress
subscale at baseline was associated with an average 0.98 and 0.81
improvement in PHQ-9 total score over time, respectively.
DISCUSSION
This study examined the longitudinal relationship of
demographic and medical variables on the one hand and
DRD or depressive symptoms on the other after 3 years of
regular primary diabetes care. Unexpectedly, from all the
possible baseline variables, only greater DRD and depressive
symptoms were significant predictors of improved depressive
symptoms and DRD at 3 years, respectively. No information was
available on what occurred in the intervening 3 years. Clearly,
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FIGURE 1 | Scatterplots. (A) Scatterplot of baseline total PHQ-9 score and
the DDS-17 change mean scores. (B) Scatterplot of baseline DDS-17 mean
score and the PHQ-9 change total score. DDS-17, the 17-item diabetes
distress scale; PHQ-9, the 9-item patient health questionnaire.
such information would be useful in forming a more detailed
picture of the determinants of changes in distress and depressive
symptoms over the whole period. Nevertheless, to facilitate
the development of effective psychological interventions, in
this study we aimed to gain insight into which baseline factors
are related to subsequent changes. This study in fact showed
that there were significant converse individual changes in
DRD and depressive symptoms, indicating that low DRD
may predispose to greater depressive symptoms some years
later, and that initially weak or absent depressive symptoms
do not prevent higher DRD at a later timepoint. In our
opinion, this important observation suggests that adequate
psychological attention should also be offered to people with
TABLE 2 | Baseline, follow-up and change scores for the DDS-17 and PHQ-9.
Emotions Mean (SD)
Baseline Follow-up Change in score
Overall DDS-17 2.3 (1.02) 2.4 (0.97) 0.1 (1.23)
Emotional burden 2.4 (1.13) 2.6 (1.15) 0.3 (1.27)
Physician distress 2.1 (1.21) 2.1 (1.15) 0.01 (1.58)
Regimen distress 2.4 (1.10) 2.4 (1.07) 0.08 (1.34)
Interpersonal distress 2.3 (1.33) 2.1 (1.20) –0.1 (1.68)
Total PHQ-9 score 4.8 (4.47) 5.0 (5.00) 0.2 (5.18)
DDS-17, the 17-item diabetes distress scale, with mean scores ranging from 1 to 6; PHQ-
9, the 9-item patient health questionnaire, with total scores ranging from 0 to 27; SD,
standard deviation.
TABLE 3 | Predictive factors of DDS-17 and PHQ-9 change scores, n = 251.
Parameter Parameter
estimate
SE 95% Confidence interval
Lower bound Upper bound
DEPENDENT VARIABLE: DDS-17 CHANGE SCORE*
Total PHQ-9 −0.06 0.020 −0.104 −0.023
DEPENDENT VARIABLE: PHQ-9 CHANGE SCORE*
Overall DDS-17 −0.98 0.348 −1.670 −0.298
DEPENDENT VARIABLE: PHQ-9 CHANGE SCORE*
Emotional burden −0.52 0.489 −1.482 0.446
Physician distress 0.10 0.426 −0.741 0.939
Regimen distress 0.28 0.544 −0.791 1.353
Interpersonal distress −0.81 0.410 −1.615 −0.002
*Covariates in the model: age, gender, ethnicity, marital status, education level,
employment status, insulin therapy, microvascular complications, macrovascular
complications, World Health Organization Quality of Life-Brief and HbA1c. DDS-17, the
17-item diabetes distress scale; PHQ-9, the 9-item patient health questionnaire; SE,
standard error.
T2DM who appear to be in a relatively good psychological
state.
Baseline DRD and depressive symptoms on the one hand
and change scores at follow-up on the other showed a negative
correlation, which appears to conflict with results from other
studies; however, these studies examined the relations between
the scores at baseline and at follow-up (Fisher et al., 2009; Burns
et al., 2015; Ehrmann et al., 2015). Using the same measures
for DRD and depressive symptoms in more than a thousand
Canadians with T2DM, with similar demographic characteristics
except for ethnicity (Burns et al., 2015), positive associations were
found between baseline DRD and depressive symptoms at 2-year
follow-up. However, in this study the relationship between DRD
and depressive symptoms was examined directly at 1-year but
only indirectly at 2-year follow-up. In that study, the coefficients
at 2-years for baseline depressive symptoms predicting DRD,
and for the baseline DRD predicting depressive symptoms, were
0.02 and 0.01, respectively. The negative coefficients (between
the baseline PHQ-9 and DDS-17 change score, and between
baseline DDS-17 and PHQ-9 change score) reported in our
study were larger (0.06 and 0.98). In another study including
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about 500 Germans with diabetes mellitus (33% with T2DM)
in an outpatient setting, higher DRD at baseline (β = 0.14, p
= 0.001) was associated with higher depressive symptoms at 6-
month follow-up (Ehrmann et al., 2015). Female gender was
associated with more or more severe depressive symptoms at
follow-up. Similarly, baseline depressive symptoms (β= 0.17,
p < 0.0001) were significantly associated with DRD at 6-
month follow-up. With the exception of BMI and T2DM, no
other variables including gender, HbA1c, diabetes duration and
late complications, were associated with DRD at follow-up.
In contrast to previous studies, our study did not find any
of these variables to be significant covariates (Fisher et al.,
2009; Ehrmann et al., 2015). This discrepancy could be related
to our use of change scores as the dependent variable, to
the longer follow-up period in the present study, or perhaps
more importantly, differences in socio-cultural backgrounds as
discussed below.
The differing relationship between DRD and depressive
symptoms in our study and the abovementionedWestern studies
is remarkable, especially in light of a recent study from Taiwan
(Wang et al., 2016). Taiwanese adults with T2DM (n = 304)
exhibiting higher levels of “empowerment” also had a higher
level of DRD at 12-months follow-up (β = 0.154, p < 0.01).
Additionally, increases in self-management behaviors interacted
with an increase in patient empowerment and were associated
with a decrease in DRD (β = –0.206, p < 0.01). In other words,
the decrease in DRD was only observed when empowerment
and self-management behaviors increased in tandem. Other
covariates that were “protective” against DRD were diabetes
self-efficacy and resilience. The empowerment referred to above
comprised the participants’ perceptions of being empowered
by their healthcare providers to better illness understanding,
self-awareness and personal control. Thus, it may be that our
participants and those in Taiwanese both had a negative reaction
to healthcare education or counseling. Likewise, well-meant
support from family members or friends might have had the
opposite effect to that intended (Rintala et al., 2013). However,
with continuous follow-up at the health clinics and support from
their “significant others” people with T2DM will subsequently
improve in self-care (Gao et al., 2013) and experience less DRD
and depressive symptoms. Another possible explanation for the
findings in both Taiwan and Malaysia might be that certain
participants expressed more DRD or depressive symptoms in
order to acquire help and attention. Within the closely-knit
social network typical of many Asian families and communities
(Lee et al., 2013), adequate and satisfying social support was
probably garnered over time, resulting in improved psychosocial
well-being, less DRD and fewer depressive symptoms (Hameed
et al., 2013; Karlsen and Bru, 2014). It is also possible that
the respective healthcare systems offered greater support to
patients who showed DRD or depressive symptoms. The
negative relationship might thus indicate that patients with a
low distress level and/or few depressive feelings at baseline
received inadequate psychological support in the following 3
years.
To the best of our knowledge, this is the first prospective
cohort study in Asian people with T2DM to examine the
relation between DRD and depressive symptoms, and with the
longest period of follow-up. Additionally, use of change scores
as the dependent variables reduces bias in the analysis, especially
when correlations between baseline and follow-up are significant
(Glymour et al., 2005). However, our design also had limitations.
Although similar to other studies (Silva Junior et al., 2015), the
participation rate in the current study was low, suggesting some
degree of self-selection. The different profiles of participants and
non-participants may have had some effect on the findings of
the study. The relative under-participation at 3-year follow-up of
ethnic Malay participants from the rural Salak health clinics, and
of those not having dyslipidemia, may have reduced the increase
in the DDS-17 change score as these groups had significantly
lower distress scores at baseline (Chew et al., 2016b). However,
differential loss of participants does not necessarily cause bias
in association estimates (Osler et al., 2008). The baseline mean
DDS-17 and PHQ-9 scores in this study were 2.3 (1.02) and
4.8 (4.47), which were high compared to those of Burns et al.
(2015), at 1.6 (0.68) and 4.2 (4.86), respectively. To some extent,
regression to the mean may have occurred, though this statistical
effect was probably limited because the mean scores for DDS-
17 and PHQ-9 were higher at follow-up than at baseline. Thus,
the relation between PHQ-9 at baseline and the DDS-17 change
score, and between DDS-17 at baseline and PHQ-9 change score
as observed in this study are plausible.
In conclusion, among Malaysian adults with T2DM who
returned regularly to health clinics and received continuous
healthcare treatment, initial depressive symptoms were
correlated with a reduced DRD at 3 years. Similarly, initial
DRD (interpersonal distress) was associated with fewer or
improved depressive symptoms. These observations require a
reconceptualization of DRD and depressive symptoms, at least
in Malaysian people with T2DM. Evidently, such feelings and
symptoms should not be considered as merely negative factors.
Nonetheless, vigilant monitoring for DRD and depressive
symptoms, combined with psychological support for those
without emotional distress, seems a reasonable approach in
diabetes care.
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